Detectability of liver metastases in malignant melanoma: prospective comparison of magnetic resonance imaging and positron emission tomography
- 31 May 2005
- journal article
- clinical trial
- Published by Elsevier in European Journal of Radiology
- Vol. 54 (2) , 264-270
- https://doi.org/10.1016/j.ejrad.2004.07.005
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Indikationen und Ergebnisse der LebermetastasenresektionDer Radiologe, 2001
- Use of fluorine-18 fluorodeoxyglucose positron emission tomography in the detection of silent metastases from malignant melanomaEuropean Journal of Nuclear Medicine and Molecular Imaging, 2000
- The National Cancer Data Base report on cutaneous and noncutaneous melanomaCancer, 1998
- Primary staging and follow-up of high risk melanoma patients with whole-body18F-fluorodeoxyglucose positron emission tomographyCancer, 1998
- Prospective evaluation of 2-[18F]-2-deoxy-D-glucose positron emission tomography in staging of regional lymph nodes in patients with cutaneous malignant melanoma.Journal of Clinical Oncology, 1998
- Effectiveness of Positron Emission Tomography for the Detection of Melanoma MetastasesAnnals of Surgery, 1998
- Positron emission tomography in the detection and management of metastatic melanomaMelanoma Research, 1996
- The incidence of malignant melanoma in the United States: Issues as we approach the 21st centuryJournal of the American Academy of Dermatology, 1996
- Staging of metastatic melanoma by whole-body positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucoseBritish Journal of Dermatology, 1995
- Malignant Melanoma: Pattern of MetastasisCA: A Cancer Journal for Clinicians, 1980